Zurcher Kantonalbank (Zurich Cantonalbank) Biotechnology

Zurcher Kantonalbank (Zurich Cantonalbank)

$33.8 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
NUVL Nuvalent, Inc.	$3.36B	$460,000 0.0% of portfolio	6,497	Q1 2025 Reduced 11.04%
SWTX Spring Works Therapeutics, Inc.	$2.92B	$455,000 0.0% of portfolio	10,313	Q1 2025 Reduced 11.74%
ACAD Acadia Pharmaceuticals Inc	$3.61B	$452,000 0.0% of portfolio	27,256	Q1 2025 Added 14.2%
PTGX Protagonist Therapeutics, Inc	$2.66B	$439,000 0.0% of portfolio	9,092	Q1 2025 Reduced 6.29%
BCRX Biocryst Pharmaceuticals Inc	$2.07B	$436,000 0.0% of portfolio	58,216	Q1 2025 Reduced 0.05%
APLS Apellis Pharmaceuticals, Inc.	$2.13B	$435,000 0.0% of portfolio	19,891	Q1 2025 Reduced 2.25%
ARWR Arrowhead Pharmaceuticals, Inc.	$1.75B	$428,000 0.0% of portfolio	33,596	Q1 2025 Reduced 0.03%
TVTX Travere Therapeutics, Inc.	$957M	$411,000 0.0% of portfolio	22,956	Q1 2025 Added 14.96%
RXRX Recursion Pharmaceuticals, Inc.	$825M	$405,000 0.0% of portfolio	76,730	Q1 2025 Added 15.46%
AGIO Agios Pharmaceuticals, Inc.	$1.84B	$376,000 0.0% of portfolio	12,836	Q4 2024 Added 5.8%
IMVT Immunovant, Inc.	$3.55B	$358,000 0.0% of portfolio	13,044	Q1 2025 Added 66.29%
ARDX Ardelyx, Inc.	$612M	$355,000 0.0% of portfolio	72,464	Q1 2025 Reduced 3.19%
IDYA Ideaya Biosciences, Inc.	$1.01B	$348,000 0.0% of portfolio	21,301	Q1 2025 Added 6.04%
AUPH Aurinia Pharmaceuticals Inc.	$1.16B	$342,000 0.0% of portfolio	42,641	Q1 2025 Added 24.5%
WVE Wave Life Sciences Ltd.	$606M	$339,000 0.0% of portfolio	41,974	Q1 2025 Added 16.73%
INVA Innoviva, Inc.	$1.48B	$338,000 0.0% of portfolio	18,649	Q1 2025 Reduced 7.05%
AKRO Akero Therapeutics, Inc.	$2.54B	$317,000 0.0% of portfolio	7,845	Q2 2024 Reduced 0.01%
KYMR Kymera Therapeutics, Inc.	$2.61B	$310,000 0.0% of portfolio	11,348	Q1 2025 Reduced 5.07%
MDXG Mimedx Group, Inc.	$720M	$301,000 0.0% of portfolio	39,713	Q1 2025 Added 18.11%
ABUS Arbutus Biopharma Corp	$517M	$293,000 0.0% of portfolio	84,163	Q1 2025 Reduced 6.14%
CLDX Celldex Therapeutics, Inc.	$913M	$289,000 0.0% of portfolio	15,930	Q4 2024 Added 12.89%
LQDA Liquidia Corp	$1.18B	$283,000 0.0% of portfolio	19,221	Q1 2025 Reduced 15.59%
RCUS Arcus Biosciences, Inc.	$711M	$280,000 0.0% of portfolio	35,748	Q1 2025 Added 7.6%
ADPT Adaptive Biotechnologies Corp	$1.41B	$273,000 0.0% of portfolio	36,754	Q1 2025 Reduced 29.69%
GERN Geron Corp	$589M	$271,000 0.0% of portfolio	170,441	Q1 2025 Added 13.39%
HRMY Harmony Biosciences Holdings, Inc.	$2.1B	$271,000 0.0% of portfolio	8,177	Q4 2024 Added 58.81%
VIR Vir Biotechnology, Inc.	$720M	$265,000 0.0% of portfolio	40,991	Q1 2025 Added 37.19%
LGND Ligand Pharmaceuticals Inc	$1.85B	$264,000 0.0% of portfolio	2,516	Q1 2025 Added 4.88%
NTLA Intellia Therapeutics, Inc.	$629M	$261,000 0.0% of portfolio	36,795	Q1 2025 Added 14.08%
VRDN Viridian Therapeutics, Inc.\De	$579M	$251,000 0.0% of portfolio	18,664	Q4 2024 Added 33.34%
TARS Tarsus Pharmaceuticals, Inc.	$1.2B	$247,000 0.0% of portfolio	4,819	Q1 2025 Reduced 17.21%
OCUL Ocular Therapeutix, Inc	$664M	$232,000 0.0% of portfolio	31,739	Q1 2025 Reduced 8.64%
VERA Vera Therapeutics, Inc.	$567M	$228,000 0.0% of portfolio	9,533	Q1 2025 Added 19.75%
NRIX Nurix Therapeutics, Inc.	$589M	$223,000 0.0% of portfolio	18,829	Q1 2025 Added 13.64%
XNCR Xencor Inc	$570M	$220,000 0.0% of portfolio	20,677	Q1 2025 Added 5.33%
KURA Kura Oncology, Inc.	$439M	$216,000 0.0% of portfolio	32,784	Q1 2025 Added 23.11%
DYN Dyne Therapeutics, Inc.	$737M	$201,000 0.0% of portfolio	19,247	Q1 2025 Added 22.2%
PRTA Prothena Corp Public LTD CO	$247M	$198,000 0.0% of portfolio	16,040	Q1 2025 Added 0.06%
JANX Janux Therapeutics, Inc.	$1.03B	$192,000 0.0% of portfolio	7,125	Q1 2025 Added 26.4%
RCKT Rocket Pharmaceuticals, Inc.	$210M	$190,000 0.0% of portfolio	28,559	Q1 2025 Added 21.8%
IOVA Iovance Biotherapeutics, Inc.	$349M	$184,000 0.0% of portfolio	55,302	Q1 2025 Reduced 5.9%
SVRA Savara Inc	$285M	$167,000 0.0% of portfolio	60,343	Q1 2025 Reduced 5.14%
SNDX Syndax Pharmaceuticals Inc	$631M	$162,000 0.0% of portfolio	13,260	Q1 2025 Reduced 26.3%
AVXL Anavex Life Sciences Corp.	$606M	$161,000 0.0% of portfolio	18,792	Q1 2025 Added 703.42%
EWTX Edgewise Therapeutics, Inc.	$936M	$155,000 0.0% of portfolio	7,073	Q1 2025 Reduced 10.37%
ETNB 89bio, Inc.	$473M	$147,000 0.0% of portfolio	20,295	Q1 2025 Added 153.85%
IBRX Immunity Bio, Inc.	$1.38B	$132,000 0.0% of portfolio	43,992	Q1 2025 Added 42.59%
CAPR Capricor Therapeutics, Inc.	$273M	$125,000 0.0% of portfolio	13,246	Q1 2025 Added 31.36%
EYPT Eye Point Pharmaceuticals, Inc.	$290M	$122,000 0.0% of portfolio	22,571	Q1 2025 Added 62.44%
DAWN Day One Biopharmaceuticals, Inc.	$511M	$113,000 0.0% of portfolio	14,269	Q4 2024 Added 104.49%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.